Phase 4 Osteoarthritis Trial, Recruiting NCT05761015 Sponsor: University Hospital, Clermont-Ferrand Condition: Osteoarthritis
Back to Osteoarthritis

Phase 4 Osteoarthritis Trial, Recruiting

NCT05761015
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with osteoarthritis (wear-and-tear joint disease) in one or both hips or knees, confirmed by an X-ray showing a certain level of joint damage, where the condition has been causing pain for at least 3 months.
  • People who experience pain when walking that rates at least 4 out of 10 in intensity.
  • People who currently do fewer than 3 walks of at least 20 minutes (or 1,000 steps) per week.
  • People who are able to understand the study instructions and complete the questionnaires involved.

Who may not be able to join:

  • People who are pregnant or breastfeeding.
  • People who are under legal guardianship or court-ordered protection.
  • People who weigh less than 40 kg or are classified as underweight.
  • People who weigh more than 120 kg or are classified as obese.
  • People who are unable to walk at all, or who cannot walk without the use of major support devices (note: walking sticks, crutches, braces, and knee supports are allowed).
  • People whose osteoarthritis is caused by another underlying condition, such as rheumatoid arthritis, a joint infection, gout, or certain metabolic disorders, rather than general wear and tear.
  • People who have another bone disease affecting the whole body, such as Paget's disease.
  • People who have another significant source of pain unrelated to osteoarthritis, such as nerve pain or fibromyalgia.
  • People who have recently had a procedure — such as surgery, keyhole joint surgery, or a joint injection — that would be expected to reduce their osteoarthritis pain during the study period.
  • People who have a similar joint procedure planned during the study period.
  • People who have recently started a new pain-relief medication, including steroid tablets or injections.
  • People who have plans to start a pain-relief program during the study period, such as physiotherapy or cognitive behavioural therapy.
  • People who have major surgery planned during the study period.
  • People who currently have cancer.
  • People whose immune system is suppressed (for example, due to medication or illness).
  • People who have an autoimmune disease.
  • People who are currently using anti-inflammatory medications (NSAIDs) applied to the skin or taken by mouth.
  • People who regularly take strong opioid pain medications.
  • People who are currently on insulin therapy.
  • People for whom anti-inflammatory medications (NSAIDs) or paracetamol (acetaminophen) are medically unsuitable, according to French medicines authority guidelines.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 04 73 75 11 95

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
14 December 2023
Est. completion
1 April 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Success

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov